July 16, 2020
According to the research report titled ‘Asia-Pacific Digital Respiratory Device Market Analysis, 2020’, available with Market Study Report LLC, Asia-Pacific digital respiratory device market is expected to grow with a CAGR of 30% during 2020-2025.
Growing public awareness and expenditure towards healthcare along with incorporation of advanced technologies in emerging nations are propelling the growth of APAC digital respiratory device market. Patient preference for digital medical equipment will impel the demand for digital respiratory devices over the forecast period.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2767195/
Moreover, rise in number of COVID-19 infected patients and surging death toll are compelling private healthcare companies and government to adopt sophisticated respiratory medical devices to detect, monitor, and prevent the spread of virus. With rise in precautionary healthcare spending in numerous countries, Asia Pacific digital respiratory device industry will register substantial growth through 2025.
Based on the product terrain, the market is categorized into diagnostics monitoring devices, respiratory therapy wearable medical device, disposables, consumables & accessories, and therapeutic devices.
The report cites that therapeutic devices segment held majority market share in the recent past. Alarming levels of air pollution, aging population, smoking habit prevalence and exposure to chemicals have led to mounting cases asthma and chronic obstructive pulmonary disease (COPD), thereby boosting the demand for therapeutic devices.
Speaking of end-user spectrum, Asia Pacific digital respiratory device market is divided into ambulatory care centers, homecare, and hospitals & clinics. With respect to indication, the market is segmented into asthma, chronic obstructive pulmonary disease, sleep apnea and infectious disease.
From regional perspective, digital respiratory device market in India is poised to grow rapidly during 2020-2025. Rapid urbanization and improving healthcare cognizance have fostered the usage of digital medical devices. High pervasiveness of chronic respiratory diseases such as COPD, emphysema, and chronic bronchitis, alongside government initiatives to enhance medical facilities in the country are contributing towards APAC market outlook.
Key players operating in Asia-Pacific digital respiratory device market include Astra Zeneca Plc, Novartis AG, Philips, GE Healthcare, 3M Healthcare, Cipla Ltd., ResMed Ltd., Teva Pharmaceuticals Industries Ltd., Masimo Corporation, and Acorda Therapeutics among others.